Drugs@FDA: FDA-Approved Drugs
Company: HARROW EYE
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
---|---|---|---|---|---|---|---|
IOPIDINE | APRACLONIDINE HYDROCHLORIDE | EQ 1% BASE | SOLUTION/DROPS;OPHTHALMIC | Prescription | None | Yes | Yes |
Original Approvals or Tentative Approvals
Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
---|---|---|---|---|---|---|---|
12/31/1987 | ORIG-1 | Approval | Type 1 - New Molecular Entity | STANDARD |
Label is not available on this site. |
Supplements
Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert | Note | Url |
---|---|---|---|---|---|
03/01/2018 | SUPPL-25 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/019779s025lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2018/019779Orig1s025ltr.pdf | |
04/06/2017 | SUPPL-23 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/019779s023lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2017/019779Orig1s023ltr.pdf | |
11/05/2015 | SUPPL-22 | Manufacturing (CMC) |
Label is not available on this site. |
||
12/15/2004 | SUPPL-19 | Labeling |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2004/19779s018,019lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2004/19779s018,019ltr.pdf | |
12/15/2004 | SUPPL-18 | Labeling |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2004/19779s018,019lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2004/19779s018,019ltr.pdf | |
05/15/2003 | SUPPL-15 | Labeling |
Letter (PDF)
|
Label is not available on this site. |
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2003/19779SLR015ltr.pdf |
03/22/2002 | SUPPL-14 | Labeling |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2002/19779S14lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2002/19779s14ltr.pdf | |
09/21/2001 | SUPPL-13 | Manufacturing (CMC)-Control |
Label is not available on this site. |
||
09/13/2000 | SUPPL-12 | Manufacturing (CMC)-Control |
Label is not available on this site. |
||
11/03/1997 | SUPPL-11 | Labeling |
Label is not available on this site. |
||
08/27/1996 | SUPPL-10 | Labeling |
Label is not available on this site. |
||
08/30/1995 | SUPPL-9 | Labeling |
Label is not available on this site. |
||
08/20/1992 | SUPPL-7 | Manufacturing (CMC)-Control |
Label is not available on this site. |
||
11/29/1990 | SUPPL-6 | Manufacturing (CMC)-Control |
Label is not available on this site. |
||
05/02/1990 | SUPPL-5 | Manufacturing (CMC) |
Label is not available on this site. |
||
12/15/1989 | SUPPL-4 | Efficacy-New Indication |
Label is not available on this site. |
||
12/11/1989 | SUPPL-3 | Labeling |
Label is not available on this site. |
||
01/03/1989 | SUPPL-2 | Manufacturing (CMC)-Expiration Date |
Label is not available on this site. |
||
03/31/1989 | SUPPL-1 | Labeling |
Label is not available on this site. |
Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert |
Note | Url |
---|---|---|---|---|---|
03/01/2018 | SUPPL-25 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/019779s025lbl.pdf | |
04/06/2017 | SUPPL-23 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/019779s023lbl.pdf | |
12/15/2004 | SUPPL-19 | Labeling | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2004/19779s018,019lbl.pdf | |
12/15/2004 | SUPPL-18 | Labeling | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2004/19779s018,019lbl.pdf | |
03/22/2002 | SUPPL-14 | Labeling | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2002/19779S14lbl.pdf |